Expands nationwide footprint of retail pharmacy customers, adding industry-leading financial management, analytics, and population health solutions to EnlivenHealth division offering
Second annual digital event focuses on enhancing medication management to help improve clinical, operational, and business outcomes
Access to expanded engineering resources will accelerate innovation for the Company’s cloud-based solutions portfolio
Supports commitment to safeguard health and wellbeing of employees, customers, and partners
New capabilities focus on superior customer experience and innovation to drive maximum value sooner; deliver improved workflow efficiency, expanded automation, and enhanced medication management intelligence
Omnicell, Inc. (NASDAQ: OMCL) announces results for its second quarter ended June 30, 2021.
End-to-End Medication Management Platform Fulfills Journey to Fully Autonomous Pharmacy
Strategic acquisition of leading pharmacy SaaS solutions provider supports the Autonomous Pharmacy vision and expands Omnicell’s Advanced Services portfolio
Omnicell has appointed Edward P. Bousa to fill the newest seat of the Company’s Board of Directors.
Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2021.
Represents Omnicell’s 148th Long-Term Partnership with a Top 300 US Health System
Omnicell Division Will Leverage Twilio's Cloud Communications Platform to Power New Personalized Communications Capabilities
Adoption of Technology-Enabled Services and Dispensing Solutions Supports Autonomous Pharmacy Vision
Expanded Partnership Demonstrates Value of Technology-Enabled Services and Autonomous Pharmacy Vision
Ms. Mellon will lead human resources functions, employee environments, and internal communications for Omnicell’s global operations.
Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2020.